Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Surgical Oncology|July 26, 2025
Updates on molecular targets and clinical trials with targeted therapies for pancreatic cancerRachael A Safyan, E Gabriela ChioreanAnti-Cancer Drugs|January 28, 2014
Taxanes: impact on pancreatic cancerE Gabriela Chiorean, Daniel D Von HoffHematology/Oncology and Stem Cell Therapy|March 19, 2015
Ocular metastasis of colorectal cancer: An uncommon presentation of a common malignancyMuhammad Rizwan Khawaja, John T Minturn, A John Spittler, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Localized Pancreatic Cancer: Multidisciplinary ManagementAndrew L Coveler, Joseph M Herman, Diane M Simeone, et al.Targeted Oncology|August 3, 2019
A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid TumorsThomas B Karasic, E Gabriela Chiorean, Said M Sebti, et al.Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation of First-Line ChemotherapyAndrea Bullock, Christopher G Rowan, Nina Oestreicher, et al.Seminars in Oncology|November 5, 2018
Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinomaDavid B Zhen, Andrew Coveler, Silvia Zanon, et al.Plos One|February 24, 2018
The role of the folate pathway in pancreatic cancer riskShirisha Chittiboyina, Zhongxue Chen, E Gabriela Chiorean, et al.Expert Review of Clinical Immunology|September 1, 2022
Combination immunotherapy for pancreatic cancer: challenges and future considerationsGustavo C L Gössling, David B Zhen, Venu G Pillarisetty, et al.Immunotherapy|January 21, 2016
Algenpantucel-L immunotherapy in pancreatic adenocarcinomaAndrew L Coveler, Gabriela R Rossi, Nicholas N Vahanian, et al.Pageof 8